Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Laboratory for Molecular Medicine, |
RCV000615704 | SCV000712121 | pathogenic | Rare genetic deafness | 2016-06-20 | criteria provided, single submitter | clinical testing | The p.Ile1919X variant in TECTA has not been previously reported in individuals with hearing loss. This variant was absent from large population studies, though the ability of these studies to accurately detect indels may be limited. This 2 bp deletion leads to a nonsense variant resulting in a premature termination cod on at position 1919, which is predicted to lead to a truncated or absent protein . Loss of function of the TECTA gene is an established disease mechanism in auto somal recessive hearing loss. In summary, this variant meets our criteria to be classified as pathogenic for hearing loss in an autosomal recessive manner based on the predicted impact of the variant on the protein. |